WRIGHT MEDICAL GROUP, INC. - FORM 8-K
 

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): November 13, 2007
WRIGHT MEDICAL GROUP, INC.
(Exact name of registrant as specified in charter)
         
Delaware   000-32883   13-4088127
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification Number)
     
5677 Airline Road, Arlington, Tennessee   38002
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: (901) 867-9971
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 


 

Item 8.01. Other Events.
Arbitration Ruling
On November 13, 2007, we received a ruling by the arbitrator in a binding arbitration involving a dispute before the American Arbitration Association with a former consultant who demanded approximately $3.6 million under a contract we terminated in 2005, as well as current and future royalties for certain of our products. The consultant claimed that we wrongfully terminated or breached a product development contract. The arbitrator awarded the former consultant $3.3 million plus interest at ten percent (10%) from December 17, 2005, until the award is paid; denied the consultant’s claim for punitive damages; cancelled a related consulting agreement between the parties; and denied the consultant’s claims for royalties for certain of our products.
We will recognize the $3.3 million plus interest within our results of operations for the three months ended December 31, 2007.

1


 

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     Date: November 13, 2007
         
  WRIGHT MEDICAL GROUP, INC.
 
 
  By:   /s/ Gary D. Henley    
    Gary D. Henley   
    President and Chief Executive Officer   
 

2